Document is current
Any future updates will be listed below
-
Authors
Alcon, Clara
Manzano-Muñoz, Albert https://orcid.org/0000-0003-4039-7391
Prada, Estela https://orcid.org/0000-0003-4611-1120
Mora, Jaume
Soriano, Aroa https://orcid.org/0000-0001-9659-1471
Guillén, Gabriela https://orcid.org/0000-0001-5632-2672
Gallego, Soledad https://orcid.org/0000-0002-4712-9624
Roma, Josep https://orcid.org/0000-0001-7692-6123
Samitier, Josep
Villanueva, Alberto https://orcid.org/0000-0001-5164-0006
Montero, Joan https://orcid.org/0000-0002-9192-4836
-
Funding
Funding for this research was provided by:
Fundación Cellex (NA, NA, NA, NA)
Ministerio de Economía y Competitividad (RYC-2015-18357)
- License Information
-
More Information
Article History
Received: 14 April 2020
Revised: 4 August 2020
Accepted: 4 August 2020
First Online: 15 August 2020
Conflict of interest
: J.M. was a consultant for Oncoheroes Biosciences and Vivid Biosciences and is a board member for The Society for Functional Precision Medicine. A.V. is cofounder of the Spin-off of XenOPAT SL and has ownership interests. No potential conflicts of interest were disclosed by the other authors.
